Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) released a profit for first quarter that Dropped, from last year
The company's earnings came in at RMB400.141 million, or RMB0.44 per share. This compares with RMB440.335 million, or RMB0.48 per share, last year.
The company's revenue for the period fell 20.9% to RMB1.207 billion from RMB1.525 billion last year.
Hubei Jumpcan Pharmaceutical Co., Ltd. earnings at a glance (GAAP) :
-Earnings: RMB400.141 Mln. vs. RMB440.335 Mln. last year.-EPS: RMB0.44 vs. RMB0.48 last year.-Revenue: RMB1.207 Bln vs. RMB1.525 Bln last year.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.